MidCap Financial

MidCap Financial

This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Headquarters Location

United States, Bethesda

About

MidCap Financial was established in 2008, and is a well known Corporate Investor. The fund is located in United States, North America. The primary office of this Corporate Investor is located in Bethesda.

Deals in the range of 50 - 100 millions dollars are most common for this fund. In comparison with other funds, MidCap Financial makes 30 percentage points more than the average number of lead investments. The fund generally invests in 2-6 deals every year. The highest number of exits from this fund were in 2014. In 2018, the fund's activity was at its peak. In addition, the fund was active in 2019. In terms of the fund's performance, this Corporate Investor has 21 percentage points more exits when compared to other organizations.

The usual method for the fund is to invest in rounds with 2 other investors. Along with MidCap Financial, start-ups are often financed by New Leaf Venture Partners, Wellington Partners, Triathlon Medical Venture Partners as well as 23 other investors. Other VCs who often invest in the same rounds are Silicon Valley Bank, Oxford Finance LLC, WuXi NextCODE. The investors in the following rounds are usually Foresite Capital, CRG L.P., WuXi NextCODE.

Also, a start-up has to be aged 11-15 years to expect investment from this fund. The country of its foundation and the country of its most frequent investments coincides - United States. Besides this, the fund also invested in 1 other country. We can highlight the most popular investment areas for this fund, such as Pharmaceutical, Medical. In addition, there are 14 more industries where it has achieved success. The fund has no an exact preference in the amount of founders of companies in its portfolio. If the applying start-up has 4 or 5+ founders, it is very unlikely that funding will be awarded. Intarcia Therapeutics, Spectranetics, DNAnexus are amongst the various portfolio companies of this fund.

Year Founded

2008

Fund Activity

Operative

Mail Rule [rules by which you can get an email of an interesting for you fund employee, knowing only the name and surname of this employee]

Domain name: midcapfinancial.com; User name format in descending order of probability: first_initial last, first last, last first_initial, first, first last_initial

Group Appearance [how often fund is operating separately from groups with shared interest]

100.0% of cases

Investments per Year [average amount of rounds in which fund participates each year]

1-3

Average Multiplicator [the average ratio of the last valuation of portfolio startups to their total amount of financing raised]

x11.2

Average Portfolio Company
Exit Age [the average age of portfolio startups at which they go public or become acquired]

1.3 years

Success / Strategy Similarity
Index [the matching between fund's investment strategy and its proved successes in the form of portfolio startups high valuations]

0.55 out of 1

Number of Unicorns [amount of portfolio companies, which were valuated at more then $1B]

2

Number of Minotaurs [amount of portfolio companies, which raised more then $1B in total]

1

Funds Investing in Following
Rounds

Foresite Capital, CRG L.P., WuXi NextCODE

If you have found a spelling error or the data isn't actual, please, notify us by selecting that text and pressing Ctrl+Enter.

Fund reviews
  • No reviews are submitted yet.
Crunchbase icon

Content report

The following text will be sent to our editors: